Chemoinformaics analysis of TERT-BUTYLANISOLE
| Molecular Weight | 164.248 | nRot | 1 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 6 |
| Exact Molecular Weight | 164.12 | nRing | 1 |
| Solubility: LogS | -3.895 | nHRing | 0 |
| Solubility: LogP | 3.73 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 29.8407 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.62 |
| Synth | 1.526 |
| Natural Product Likeliness | -0.562 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.263 |
| Pgp-sub | 0.005 |
| HIA | 0.008 |
| CACO-2 | -4.486 |
| MDCK | 0.0000203 |
| BBB | 0.388 |
| PPB | 0.948643 |
| VDSS | 3.712 |
| FU | 0.0823777 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.949 |
| CYP2c19-inh | 0.78 |
| CYP2c19-sub | 0.901 |
| CYP2c9-inh | 0.379 |
| CYP2c9-sub | 0.802 |
| CYP2d6-inh | 0.55 |
| CYP2d6-sub | 0.885 |
| CYP3a4-inh | 0.277 |
| CYP3a4-sub | 0.634 |
| CL | 8.329 |
| T12 | 0.502 |
| hERG | 0.037 |
| Ames | 0.005 |
| ROA | 0.038 |
| SkinSen | 0.383 |
| Carcinogencity | 0.16 |
| EI | 0.99 |
| Respiratory | 0.141 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.786482 |